GT Biopharma to be Added to the Russell 2000® Index
BEVERLY HILLS, Calif., June 8, 2021 /PRNewswire/ — GT Biopharma, Inc. (“GT Biopharma” or the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company’s proprietary natural killer (NK) cell engager (TriKE™)…
Comments Off on GT Biopharma to be Added to the Russell 2000® Index